Safety and Efficacy of TOP1630 for Dry Eye Syndrome
Status:
Completed
Trial end date:
2017-06-15
Target enrollment:
Participant gender:
Summary
In subjects with Dry Eye Syndrome:
The primary objective of this study is to compare the safety and tolerability of TOP1630
Ophthalmic Solution to placebo.
The secondary objectives are to compare the efficacy of TOP1630 Ophthalmic Solution to
placebo for the treatment of the signs and symptoms of dry eye syndrome.